Viewing Study NCT06083857


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-05 @ 5:47 PM
Study NCT ID: NCT06083857
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-10
First Post: 2023-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module